Social Media Newsroom
About
ImpriMed is a biotech startup that innovates the method of cancer care based on science and medicine. Our goal is to help oncologists provide more tailored treatment approaches; based on data-driven artificial intelligence from ex vivo cellular data.
ImpriMed is a fast-growing, dynamic team of experts who will not rest until their mission is accomplished, which is to provide precision medicine for pet cancer care to all.
Connect
Press Contact
- Name
- Mary Ocnean
- Phone
- 650-521-0165
- Contact Us
- Website
- https://www.imprimedicine.com
Press Releases
ImpriMed Launches Advanced Precision Medicine Service for Canine Blood Cancers
×
Volume Pricing
We know many of you need to send dozens or even hundreds of press releases each month for your clients or your company, and we allow multiple newsrooms so you can manage multiple clients. We also do offer volume pricing for clients who can commit to a specific number of press releases each month.
NOTE: This is for our core distribution service and NOT the US National distribution plan.
The core distribution service goes to Google News, Twitter, DigitalJournal.com and ~150+ news and TV websites (See sites).
If you are looking to send 10 or more Releases per month, please fill out the form below to contact us
